European Urology Names Fox Chase Cancer Center’s Dr. Andres F. Correa Reviewer of the Month

Press Release

In Partnership With:

Partner | Cancer Centers | <b>Fox Chase Cancer Center</b>

The journal European Urology has named Fox Chase Cancer Center urologic oncologist Andres F. Correa, MD, its March 2024 Reviewer of the Month.

The journal European Urology has named Fox Chase Cancer Center urologic oncologist Andres F. Correa, MD, its March 2024 Reviewer of the Month.

“I am truly honored by this distinction from European Urology and having the privilege of being a reviewer of the cutting-edge urologic oncology research submitted to the journal. Involvement in the review process for this prestigious journal has allowed me to remain inquisitive and current with our fast-evolving field. It goes hand in hand with my role as Director of Research in the Department of Urology here at Fox Chase,” said Correa, who is also an Assistant Professor in the department and the Society of Urologic Oncology’s Fellowship Director.

“This huge international recognition by the top journal in our field is a testament to Dr. Correa’s exceptional expertise and dedication,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology. Correa, who was a Society of Urologic Oncology Fellow at Fox Chase, returned to the center in 2020. He received his medical degree from the University of Maryland School of Medicine, where he graduated magna cum laude. Correa was a general surgery intern at the University of Pittsburgh Medical Center before becoming a urology resident and eventually the urology chief resident.

Correa is skilled at all surgical modalities, including robotics, laparoscopy, and traditional open surgery, and has deep expertise in prostate, kidney, bladder, testicular, and other genitourinary cancers.

“Fox Chase Urologic Oncology is extremely fortunate to be home to talent of such high caliber,” said Kutikov.

Correa is a member of the American Medical Association, National Hispanic Medical Association, American Urological Association, and the Society of Urologic Oncology.

He has published numerous manuscripts in peer-reviewed journals, including seminal work on prediction of kidney cancer recurrence in the prestigious Journal of Clinical Oncology, and has presented at numerous academic meetings and contributed to book chapters in the field.

Correa was named a Top Doctor by Philadelphia magazine. He is fluent in Spanish and has been nominated as a top doctor in the Philadelphia area by Al Día News Media.